| dc.contributor.author | Shumate, Timothy | |
| dc.contributor.editor | Martin, David | |
| dc.contributor.editor | Godfrey, Nelda | |
| dc.coverage.temporal | Fall 2012 - Spring 2013 | en_US |
| dc.date.accessioned | 2013-06-28T20:55:53Z | |
| dc.date.available | 2013-06-28T20:55:53Z | |
| dc.date.created | 2013 | en_US |
| dc.date.issued | 2013-08-01 | en_US |
| dc.identifier.uri | http://hdl.handle.net/2271/1175 | en_US |
| dc.description | About the author: Tim Shumate is from Wichita, Kansas. He was the recipient of the John F. and Ella Hull Scholarship while a student. He is starting his career in the Wichita area in an acute care setting. In his future he sees himself becoming involved in nursing leadership and management then eventually returning to school for a Doctorate of Nursing Practice with specialization in Family Medicine. He thanks his wife Lindsay for all the time she spent editing and discussing his papers and for her continued support throughout his journey of becoming a nurse. He also credits the School of Nursing at KU for providing one of the best experiences of his life. | |
| dc.description.abstract | The use of psychedelic drugs, such as lysergic acid diethylamide (LSD), 3,4- methylenedioxymethamphetamine (MDMA), and 4-phosphoryloxy- N,N -dimethyltryptamine (psilocybin), in the clinical treatment of mental health disorders has sparked a broad spectrum ethical debate amongst both the medical field and the general public. This is due to the negative connotations of the drugs being illegal and that they are used by subpopulations of our society for recreational use. The purpose of this paper is to discuss the positive implications of the use of the psychedelic drugs towards mental well-being of patients and explore the role of a nurse in its clinical application. | |
| dc.description.sponsorship | UNIVERSITY OF KANSAS SCHOOL OF NURSING BACHELOR OF SCIENCE IN NURSING PROGRAM AND DELTA CHAPTER OF SIGMA THETA INTERNATIONAL | |
| dc.description.tableofcontents | Editorial. Closer Look at Visitation Hour Policies in Intensive Care Units -- Banh, M. Expanding Donor Criteria: Is it Safe? -- Barkman, A. Intimate Partner Violence Screening: A Nursing Concern? -- Friesen, K. Taking the Guess Out of the Gender Game: Ethical Issues in Pre-Conception Sex Selection -- McShane, F. Let's Talk About Sex -- Mikulan, K. Legal and Ethical Issues Concerning Pro_Life Choices -- O'Malley, C. Medical Marijuana: The Legal and Clinical Facts Regarding Medical Use -- Ramsey, A. The Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness -- Shumate, T. Ethical Issues of Children as Research Subjects -- Truong, M. N. | |
| dc.format.extent | 8 pages | en_US |
| dc.language.iso | en_US | en_US |
| dc.subject | Psychedelic Drugs | |
| dc.subject | Drug Therapies | |
| dc.subject | Mental Illness | |
| dc.title | The Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness | |
| dc.type | Article | en_US |
| dc.rights.accessrights | openAccess | en_US |
